Mizuho maintains Sarepta Therapeutics stock rating, lowers Elevidys sales forecast – RP Digital

Business

Mizuho maintains Sarepta Therapeutics stock rating, lowers Elevidys sales forecast

August 25, 20251 min0

Mizuho maintains Sarepta Therapeutics stock rating, lowers Elevidys sales forecast

Source link

rpdigital

Leave a Reply Cancel reply

Related Articles

BancFirst declares quarterly dividend and trust interest payment

rpdigitalAugust 28, 20250

Jefferies raises Ollie's Bargain Outlet stock price target to $135 on strong growth

rpdigitalAugust 28, 20250